Sugar and Cancer

Share this content:
The data regarding sugar consumption and the increased risk of cancer are not consistent, making it difficult to draw definitive conclusions.
The data regarding sugar consumption and the increased risk of cancer are not consistent, making it difficult to draw definitive conclusions.

The belief that sugar consumption promotes cancer development and progression is based on the Warburg hypothesis, in which cancer cells preferably produce adenosine triphosphate (ATP) by glycolysis instead of oxidative phosphorylation.1 As a result, cancer cells have increased glucose uptake compared with normal cells.

No randomized, controlled trials have evaluated the direct effect of sugar consumption on cancer risk or progression, though several prospective cohort/case-control studies evaluated sugar intake directly or indirectly through dietary pattern, carbohydrate intake, and glycemic load.

Sugar Intake and Cancer Outcomes

The NIH-AARP prospective cohort study included 353,751 subjects aged 50 to 71 who completed a food frequency questionnaire and were followed for 13 years.2 The amount of added sugars, defined as sugars added at the table or as ingredients in prepared or processed foods, sucrose, and fructose, were determined.

Total sugar, added sugars, fructose, added fructose, sucrose, and added sucrose were not associated with cancer-related mortality among women or men, though total sugars (P <.0001 and .03, respectively) and fructose (P < .0001 and .002, respectively) were significantly associated with all-cause mortality among women and men.

An analysis of the CALGB 89803 trial of adjuvant chemotherapy for stage III colon cancer evaluated the effect of sugar-sweetened beverages on recurrence and mortality.3 Sugar-sweetened beverages were defined as 12 oz servings of sugar-sweetened sodas and other beverages, including fruit drinks and lemonade.

Consumption of at least 2 servings of sweetened-beverages per day was significantly associated with worse colon cancer–free survival (hazard ratio [HR], 1.67; 95% CI, 1.04-2.68; P = .02) and recurrence-free survival (HR, 1.84; 95% CI, 1.12-3.04; P = .02), but not overall survival, compared with the lowest intake of less than 2 servings per month. The association was stronger among patients who had a body mass index of 25 kg/m2 or more and those who were less physically active.

Sugar Intake and Cancer Risk

Another analysis of the NIH-AARP cohort demonstrated that high levels of total sugar intake were significantly associated with increased incidence of pleural cancer (HR, 2.64; 95% CI, 1.33-5.24; P = .006). Similarly, high levels of added sugars were associated with increased incidence of pleural cancer (HR, 2.90; 95% CI, 1.35-6.24; P = .03) and esophageal cancer (HR, 1.44; 95% CI, 1.03-2.03; P = .007).4

A protective effect, however, was associated with some types of sugar intake and other cancer types, such as higher levels of total sugar and oral cancer (HR 0.71; 95% CI, 0.54-0.93; P = .01), which may call into question the validity of these findings.

Page 1 of 2

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters